Global Pharma Grade Glycine Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Pharma Grade Glycine Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Pharma Grade Glycine Market Size Growth Rate by Product
  • 1.4.2 Chloroacetic Acid Amide Solution
  • 1.4.3 Biosynthesis
• 1.5 Market by End User
  • 1.5.1 Global Pharma Grade Glycine Market Size Growth Rate by End User
  • 1.5.2 Hospitals
  • 1.5.3 Labs
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Pharma Grade Glycine Market Size
  • 2.1.1 Global Pharma Grade Glycine Revenue 2014-2025
  • 2.1.2 Global Pharma Grade Glycine Sales 2014-2025
• 2.2 Pharma Grade Glycine Growth Rate by Regions
  • 2.2.1 Global Pharma Grade Glycine Sales by Regions
  • 2.2.2 Global Pharma Grade Glycine Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Pharma Grade Glycine Sales by Manufacturers
  • 3.1.1 Pharma Grade Glycine Sales by Manufacturers
  • 3.1.2 Pharma Grade Glycine Sales Market Share by Manufacturers
  • 3.1.3 Global Pharma Grade Glycine Market Concentration Ratio (CR5 and HHI)
• 3.2 Pharma Grade Glycine Revenue by Manufacturers
  • 3.2.1 Pharma Grade Glycine Revenue by Manufacturers (2014-2019)
  • 3.2.2 Pharma Grade Glycine Revenue Share by Manufacturers (2014-2019)
• 3.3 Pharma Grade Glycine Price by Manufacturers
• 3.4 Pharma Grade Glycine Manufacturing Base Distribution, Product Types
  • 3.4.1 Pharma Grade Glycine Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Pharma Grade Glycine Product Type
  • 3.4.3 Date of International Manufacturers Enter into Pharma Grade Glycine Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Pharma Grade Glycine Sales by Product
• 4.2 Global Pharma Grade Glycine Revenue by Product
• 4.3 Pharma Grade Glycine Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Pharma Grade Glycine Breakdown Data by End User

6 North America

• 6.1 North America Pharma Grade Glycine by Countries
  • 6.1.1 North America Pharma Grade Glycine Sales by Countries
  • 6.1.2 North America Pharma Grade Glycine Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Pharma Grade Glycine by Product
• 6.3 North America Pharma Grade Glycine by End User

7 Europe

• 7.1 Europe Pharma Grade Glycine by Countries
  • 7.1.1 Europe Pharma Grade Glycine Sales by Countries
  • 7.1.2 Europe Pharma Grade Glycine Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Pharma Grade Glycine by Product
• 7.3 Europe Pharma Grade Glycine by End User

8 Asia Pacific

• 8.1 Asia Pacific Pharma Grade Glycine by Countries
  • 8.1.1 Asia Pacific Pharma Grade Glycine Sales by Countries
  • 8.1.2 Asia Pacific Pharma Grade Glycine Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Pharma Grade Glycine by Product
• 8.3 Asia Pacific Pharma Grade Glycine by End User

9 Central & South America

• 9.1 Central & South America Pharma Grade Glycine by Countries
  • 9.1.1 Central & South America Pharma Grade Glycine Sales by Countries
  • 9.1.2 Central & South America Pharma Grade Glycine Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Pharma Grade Glycine by Product
• 9.3 Central & South America Pharma Grade Glycine by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Pharma Grade Glycine by Countries
  • 10.1.1 Middle East and Africa Pharma Grade Glycine Sales by Countries
  • 10.1.2 Middle East and Africa Pharma Grade Glycine Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Pharma Grade Glycine by Product
• 10.3 Middle East and Africa Pharma Grade Glycine by End User

11 Company Profiles

• 11.1 Ajinomoto
  • 11.1.1 Ajinomoto Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Ajinomoto Pharma Grade Glycine Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Ajinomoto Pharma Grade Glycine Products Offered
  • 11.1.5 Ajinomoto Recent Development
• 11.2 GEO Specialty Chemicals
  • 11.2.1 GEO Specialty Chemicals Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 GEO Specialty Chemicals Pharma Grade Glycine Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 GEO Specialty Chemicals Pharma Grade Glycine Products Offered
  • 11.2.5 GEO Specialty Chemicals Recent Development
• 11.3 Showa Denko KK
  • 11.3.1 Showa Denko KK Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Showa Denko KK Pharma Grade Glycine Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Showa Denko KK Pharma Grade Glycine Products Offered
  • 11.3.5 Showa Denko KK Recent Development
• 11.4 Chattem Chemicals
  • 11.4.1 Chattem Chemicals Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Chattem Chemicals Pharma Grade Glycine Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Chattem Chemicals Pharma Grade Glycine Products Offered
  • 11.4.5 Chattem Chemicals Recent Development
• 11.5 Paras Intermediates Private Limited
  • 11.5.1 Paras Intermediates Private Limited Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Paras Intermediates Private Limited Pharma Grade Glycine Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Paras Intermediates Private Limited Pharma Grade Glycine Products Offered
  • 11.5.5 Paras Intermediates Private Limited Recent Development
• 11.6 Evonik
  • 11.6.1 Evonik Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Evonik Pharma Grade Glycine Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Evonik Pharma Grade Glycine Products Offered
  • 11.6.5 Evonik Recent Development
• 11.7 Shijiazhuang Donghua Jinlong Chemical
  • 11.7.1 Shijiazhuang Donghua Jinlong Chemical Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Shijiazhuang Donghua Jinlong Chemical Pharma Grade Glycine Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Shijiazhuang Donghua Jinlong Chemical Pharma Grade Glycine Products Offered
  • 11.7.5 Shijiazhuang Donghua Jinlong Chemical Recent Development
• 11.8 Hebei Donghua Jiheng Chemical
  • 11.8.1 Hebei Donghua Jiheng Chemical Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Hebei Donghua Jiheng Chemical Pharma Grade Glycine Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Hebei Donghua Jiheng Chemical Pharma Grade Glycine Products Offered
  • 11.8.5 Hebei Donghua Jiheng Chemical Recent Development
• 11.9 Linxi Hongtai
  • 11.9.1 Linxi Hongtai Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Linxi Hongtai Pharma Grade Glycine Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Linxi Hongtai Pharma Grade Glycine Products Offered
  • 11.9.5 Linxi Hongtai Recent Development
• 11.10 Hubei Xingfa Chemicals Group
  • 11.10.1 Hubei Xingfa Chemicals Group Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Hubei Xingfa Chemicals Group Pharma Grade Glycine Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Hubei Xingfa Chemicals Group Pharma Grade Glycine Products Offered
  • 11.10.5 Hubei Xingfa Chemicals Group Recent Development
• 11.11 Hebei Donghuajian Chemicals
• 11.12 Zhenxing Chemical
• 11.13 Newtrend Group

12 Future Forecast

• 12.1 Pharma Grade Glycine Market Forecast by Regions
  • 12.1.1 Global Pharma Grade Glycine Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Pharma Grade Glycine Revenue Forecast by Regions 2019-2025
• 12.2 Pharma Grade Glycine Market Forecast by Product
  • 12.2.1 Global Pharma Grade Glycine Sales Forecast by Product 2019-2025
  • 12.2.2 Global Pharma Grade Glycine Revenue Forecast by Product 2019-2025
• 12.3 Pharma Grade Glycine Market Forecast by End User
• 12.4 North America Pharma Grade Glycine Forecast
• 12.5 Europe Pharma Grade Glycine Forecast
• 12.6 Asia Pacific Pharma Grade Glycine Forecast
• 12.7 Central & South America Pharma Grade Glycine Forecast
• 12.8 Middle East and Africa Pharma Grade Glycine Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Pharma Grade Glycine Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details